supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Arachidonic Acid
drug:
Rolipram
Research Papers that Mention the Interaction
“In vivo, rolipram inhibited arachidonic acid-induced inflammation in the mouse, while the lowKm-cyclic-GMP PDE inhibitor, zaprinast, did not inhibit.”
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response“ Rolipram inhibited arachidonic acid release and phosphatidylbutanol formation.”
Effects of selective phosphodiesterase type IV inhibitor, rolipram, on signal transducing phospholipases in neutrophil: inhibition of phospholipases A2, D but not C.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback